Docusign (NASDAQ:DOCU) Now Covered by Analysts at FBN Securities

FBN Securities started coverage on shares of Docusign (NASDAQ:DOCU) in a research note released on Tuesday morning, BenzingaRatingsTable reports. The firm issued an outperform rating and a $60.00 target price on the stock.

A number of other equities analysts also recently issued reports on DOCU. William Blair reissued an outperform rating on shares of Vail Resorts in a report on Friday, June 7th. Piper Jaffray Companies dropped their price objective on shares of Zafgen from $18.00 to $6.00 and set a hold rating on the stock in a report on Monday, March 11th. Wedbush set a $17.00 price objective on shares of Zumiez and gave the stock a sell rating in a report on Friday, June 7th. Finally, ValuEngine raised shares of Zogenix from a buy rating to a strong-buy rating in a report on Thursday, June 27th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock presently has an average rating of Buy and a consensus price target of $61.36.

Shares of DOCU stock opened at $53.20 on Tuesday. The business has a 50 day moving average of $51.95. Docusign has a 52 week low of $35.06 and a 52 week high of $68.35. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.76 and a quick ratio of 1.76.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, June 6th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.30. The company had revenue of $213.96 million for the quarter, compared to the consensus estimate of $208.15 million. Docusign had a negative net margin of 26.54% and a negative return on equity of 22.27%. The firm’s revenue was up 37.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.01 earnings per share. Equities research analysts anticipate that Docusign will post -0.99 EPS for the current fiscal year.

In other Docusign news, COO Scott V. Olrich sold 10,000 shares of Docusign stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $53.39, for a total transaction of $533,900.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CRO Loren Alhadeff sold 11,579 shares of Docusign stock in a transaction that occurred on Wednesday, June 19th. The shares were sold at an average price of $53.12, for a total transaction of $615,076.48. The disclosure for this sale can be found here. Insiders have sold 600,988 shares of company stock worth $31,067,181 in the last ninety days. Insiders own 13.60% of the company’s stock.

Large investors have recently modified their holdings of the business. Sonora Investment Management LLC bought a new stake in shares of Docusign during the first quarter valued at approximately $31,000. Clean Yield Group bought a new stake in shares of Docusign during the first quarter valued at approximately $31,000. Legacy Advisors LLC bought a new stake in shares of Docusign during the first quarter valued at approximately $38,000. Rehmann Capital Advisory Group raised its position in shares of Docusign by 226.1% during the first quarter. Rehmann Capital Advisory Group now owns 874 shares of the company’s stock valued at $45,000 after buying an additional 606 shares during the last quarter. Finally, Shine Investment Advisory Services Inc. bought a new stake in Docusign in the first quarter worth $66,000. 61.15% of the stock is currently owned by institutional investors and hedge funds.

Docusign Company Profile

DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.

Recommended Story: Strangles

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.